Overview

A Study of Olomorasib (LY3537982) in Healthy Japanese Participants

Status:
NOT_YET_RECRUITING
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare and see how food affects the amount of olomorasib in the blood when olomorasib is taken in two different capsule forms. Participation in the study will last approximately 6 weeks.
Phase:
PHASE1
Details
Lead Sponsor:
Eli Lilly and Company